Saturday 17 October 2026
Export AGL’s income statement to Excel — free account
Agilon Health, Inc.
AGL Healthcare Medical Care Facilities
Agilon Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, down 2.11% from fiscal 2024. In the quarter to June 2026, revenue grew 7.15%, EPS grew 117.1%, free cash flow fell 50.2% and total debt fell 13.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.
85.12
3.33
−3.76%
Follow AGL
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 5 | — | 3 | — | 3 | 3 | 3 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | 12.32 | — | 6.99 | 4.17 | 2.24 | 1.45 |
P/S ratio |
7.53 | 7.53 | 7.53 | 7.53 | 6.62 | 6.80 | 2.74 | 1.22 | 0.13 | 0.05 |
Altman Z″-Score (non-manufacturers) |
(5.39) | — | (4.89) | — | 2.95 | — | 2.74 | (0.84) | (2.57) | (7.30) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(247.27) | (247.27) | (247.27) | (247.27) | (205.92) | (211.64) | (131.04) | (86.44) | 47.56 | (13.89) |
Beneish M-Score |
(2.81) | — | (2.40) | — | (2.23) | — | (1.77) | (1.01) | 7.30 | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 9.22 | 9.48 | 6.29 | 8.00 | 1.66 | 2.25 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 10.12 | 10.40 | 6.42 | 9.23 | 2.09 | 4.68 |
EV/Sales |
7.52 | 7.52 | 7.52 | 7.52 | 5.96 | 6.14 | 2.39 | 1.12 | 0.07 | 0.01 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(148.42) | (148.42) | (148.42) | (148.42) | (61.17) | (63.06) | (43.59) | (30.93) | (7.25) | (0.33) |
EV/FCF |
(136.12) | (136.12) | (136.12) | (136.12) | (56.09) | (57.82) | (34.88) | (25.18) | (4.23) | (0.24) |
Quick Ratio |
1.16 | 1.05 | 1.05 | 3.78 | 3.78 | 2.65 | 2.58 | 1.47 | 1.23 | 0.89 |
Current Ratio |
1.23 | 1.10 | 1.10 | 3.83 | 3.83 | 2.71 | 2.71 | 1.51 | 1.27 | 1.02 |
Net Debt/EBITDA |
1.06 | 1.37 | 1.58 | 2.72 | 2.81 | 8.30 | 9.22 | 2.15 | 1.38 | 0.58 |
Debt/Assets |
17.42% | 17.04% | 15.17% | 3.72% | 3.05% | 3.36% | 2.56% | 2.21% | 2.01% | 2.75% |
Debt/Equity |
(0.30) | (0.27) | (0.24) | 0.05 | 0.04 | 0.05 | 0.04 | 0.06 | 0.07 | 0.28 |
Asset Turnover |
1.97 | 0.00 | 2.87 | 0.00 | 1.50 | 0.00 | 1.45 | 2.51 | 3.49 | 3.95 |
Operating CF/Net income |
0.37 | 0.67 | 0.89 | 0.36 | 0.36 | 1.22 | 1.23 | 0.59 | 0.22 | 0.27 |
Capex/Depreciation |
(0.09) | 0.00 | (0.17) | 0.00 | (0.92) | 0.00 | (2.37) | (1.53) | (1.69) | (1.51) |
Interest Coverage |
(11.75) | — | (6.97) | — | (60.57) | — | (23.50) | (34.87) | (47.29) | (69.75) |
| 121.80% | 0.00% | 23.24% | 0.00% | (100.76%) | 0.00% | (9.99%) | (30.86%) | (45.96%) | (130.95%) | |
| (70.14%) | 0.00% | (14.14%) | 0.00% | (40.00%) | 0.00% | (6.49%) | (15.27%) | (14.97%) | (26.04%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | (273.14%) | 0.00% | (33.56%) | (70.95%) | (182.11%) | 0.00% |
Return on Tangible Assets |
(532.48%) | (186.05%) | (177.57%) | (39.48%) | (39.88%) | (11.28%) | (11.38%) | (49.50%) | (77.90%) | (857.67%) |
Average Days of Receivables |
42.85 | 43.45 | 43.31 | 58.31 | 70.39 | 67.12 | 75.25 | 79.70 | 61.25 | 41.45 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
15.46% | 11.25% | 11.27% | 24.15% | 28.10% | 7.98% | 8.70% | 6.62% | 4.44% | 4.02% |
Intangible Assets out of Total Assets |
0.28 | 0.23 | 0.23 | 0.06 | 0.06 | 0.06 | 0.01 | 0.05 | 0.06 | 0.05 |
Share Based Compensation of Revenue |
0.66% | 0.00% | 0.55% | 0.00% | 19.22% | 0.00% | 1.19% | 1.61% | 0.84% | 0.83% |
Graham Net Nets |
(0.04) | (0.04) | (0.04) | (0.04) | 0.09 | 0.08 | 0.12 | 0.08 | 0.25 | (0.17) |
Graham Number |
0.00 | 0.00 | 47.94 | 48.88 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.60%) | (0.60%) | (0.60%) | (0.60%) | (3.96%) | (3.86%) | (1.62%) | (5.03%) | (33.16%) | (137.84%) |
Free Cash Flow Yield |
(0.73%) | (0.73%) | (0.73%) | (0.73%) | (1.60%) | (1.56%) | (2.50%) | (3.63%) | (12.69%) | (52.18%) |
Revenue per Share |
67.38 | 3.12 | 94.16 | 4.59 | 102.00 | 6.64 | 146.28 | 263.89 | 368.68 | 358.27 |
Operating CF per Share |
(8.81) | (0.14) | (4.11) | (0.37) | (9.93) | (0.32) | (8.01) | (9.55) | (3.51) | (6.39) |
Capex per Share |
(0.33) | 0.00 | (0.18) | 0.00 | (0.90) | 0.00 | (2.00) | (1.88) | (2.51) | (2.60) |
Free Cash Flow per Share |
(9.14) | (0.14) | (4.29) | (0.37) | (10.83) | (0.32) | (10.01) | (11.43) | (6.03) | (8.99) |
Cash per Share |
11.80 | 0.35 | 10.45 | 2.64 | 70.71 | 2.25 | 54.38 | 30.27 | 24.67 | 17.22 |
Shareholders Equity per Share |
(19.68) | (0.73) | (22.01) | 2.73 | 73.18 | 2.55 | 63.74 | 40.41 | 28.65 | 7.65 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(19.68) | (0.73) | (22.01) | 2.73 | 73.18 | 2.55 | 63.74 | 40.41 | 28.65 | 7.65 |
Free Cash Flow |
(107.77) | (53.20) | (55.55) | (148.16) | (161.58) | (130.81) | (163.47) | (187.01) | (99.06) | (148.87) |
Working Capital |
45.92 | 27.00 | 27.36 | 1,010.00 | 1,010.24 | 916.00 | 916.18 | 502.92 | 305.77 | 20.21 |
Capital Expenditures |
(3.91) | (2.35) | (2.35) | (13.43) | (13.43) | (32.66) | (32.66) | (30.81) | (41.28) | (43.11) |
Net Current Asset Value |
(389.29) | (128.00) | (436.89) | 872.00 | 872.54 | 794.00 | 794.42 | 400.23 | 194.74 | (47.86) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
5.79 | 0.88 | 2.18 | 0.70 | 1.60 | 0.42 | 0.69 | 0.73 | 0.87 | 1.13 |
Cash ROIC |
474.91% | 71.90% | 67.88% | (6.72%) | (7.36%) | (6.48%) | (8.29%) | (15.65%) | (10.87%) | (33.31%) |
Accounts Receivable Turnover |
8.53 | 0.00 | 10.25 | 0.00 | 6.95 | 0.00 | 6.08 | 6.02 | 6.19 | 7.02 |
Accounts Payable Turnover |
6.07 | 0.00 | 13.64 | 0.00 | 13.85 | 0.00 | 15.68 | 20.37 | 26.34 | 35.03 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
32.19 | 82.43 | 31.57 | 71.89 | 28.32 | 73.56 | 28.44 | 20.58 | 13.28 | 7.64 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
93.13 | 119.13 | 118.90 | 218.78 | 218.98 | 395.70 | 392.89 | 717.41 | 979.75 | 845.42 |
Average Payables |
126.28 | 162.28 | 82.40 | 223.12 | 105.10 | 319.47 | 145.19 | 208.43 | 229.89 | 173.91 |
Average Assets |
402.90 | 424.40 | 424.58 | 1,016.18 | 1,016.31 | 1,641.63 | 1,641.86 | 1,719.17 | 1,737.42 | 1,502.64 |
Average Common Equity |
(232.01) | (258.51) | (258.38) | 403.64 | 403.43 | 1,066.30 | 1,066.10 | 850.82 | 565.99 | 298.84 |
Columns are period end dates